M2 macrophages, but not M1 macrophages, support megakaryopoiesis by upregulating PI3K-AKT pathway activity

Abstract

Dysfunctional megakaryopoiesis hampers platelet production, which is closely associated with thrombocytopenia (PT). Macrophages (MФs) are crucial cellular components in the bone marrow (BM) microenvironment. However, the specific effects of M1 MФs or M2 MФs on regulating megakaryocytes (MKs) are largely unknown. In the current study, aberrant BM-M1/M2 MФ polarization, characterized by increased M1 MФs and decreased M2 MФs and accompanied by impaired megakaryopoiesis-supporting abilities, was found in patients with PT post-allotransplant. RNA-seq and western blot analysis showed that the PI3K-AKT pathway was downregulated in the BM MФs of PT patients. Moreover, in vitro treatment with PI3K-AKT activators restored the impaired megakaryopoiesis-supporting ability of MФs from PT patients. Furthermore, we found M1 MФs suppress, whereas M2 MФs support MK maturation and platelet formation in humans. Chemical inhibition of PI3K-AKT pathway reduced megakaryopoiesis-supporting ability of M2 MФs, as indicated by decreased MK count, colony-forming unit number, high-ploidy distribution, and platelet count. Importantly, genetic knockdown of the PI3K-AKT pathway impaired the megakaryopoiesis-supporting ability of MФs both in vitro and in a MФ-specific PI3K-knockdown murine model, indicating a critical role of PI3K-AKT pathway in regulating the megakaryopoiesis-supporting ability of M2 MФs. Furthermore, our preliminary data indicated that TGF-β released by M2 MФs may facilitate megakaryopoiesis through upregulation of the JAK2/STAT5 and MAPK/ERK pathways in MKs. Taken together, our data reveal that M1 and M2 MФs have opposing effects on MKs in a PI3K-AKT pathway-dependent manner, which may lead to new insights into the pathogenesis of thrombocytopenia and provide a potential therapeutic strategy to promote megakaryopoiesis.

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing

“…The PI3K/AKT signaling pathway is at the core of T cell activation, and it acts downstream of the T cell activation signal [ 29 , 30 ]; its main function is to promote T cell glycolysis, and it plays a key role in regulating T cell differentiation and activity [ 31 , 32 ]. However, continuous activation of this pathway promotes terminal differentiation of T cells and loss of memory, which affects T cell function [ 33 ].…”

Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes

“…Cell migration [ 28 – 30 , 39 , 40 , 43 ] was assayed using a transwell chamber (Corning, New York, USA). The EPCs after 7 days of culture were seeded in the upper chambers at a density of 4 × 10 4 cells per well, while 500 μl medium was added to the lower chamber.…”

Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials

“… 39 Accumulating evidence both in vitro and in vivo has indicated that PI3K signaling is a critical factor for driving M2 polarization and M2-like TAMs-induced tumor cell invasion. 40 Among the PI3K families, PI3Kγ has been found to be involved in various steps of macrophage activation and function. 41 Inhibition of PI3Kγ can block the immunosuppressive effects of TAMs, enhancing the activation of cluster of CD8 + T cells and responses to immune checkpoint inhibitors.…”